AUTOSOMAL DOMINANT HYPOCALCEMIA TYPE 1
Clinical trials for AUTOSOMAL DOMINANT HYPOCALCEMIA TYPE 1 explained in plain language.
Never miss a new study
Get alerted when new AUTOSOMAL DOMINANT HYPOCALCEMIA TYPE 1 trials appear
Sign up with your email to follow new studies for AUTOSOMAL DOMINANT HYPOCALCEMIA TYPE 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to fix calcium levels in rare genetic disease
Disease control OngoingThis study tests a new drug called encaleret against usual treatments for people with a rare genetic condition called autosomal dominant hypocalcemia type 1 (ADH1), which causes low blood calcium and high urine calcium. About 67 participants will receive either encaleret or stand…
Matched conditions: AUTOSOMAL DOMINANT HYPOCALCEMIA TYPE 1
Phase: PHASE3 • Sponsor: Calcilytix Therapeutics, Inc., a BridgeBio company • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New study monitors rare calcium disorder to better understand its long-term effects
Knowledge-focused OngoingThis study is for people with autosomal dominant hypocalcemia types 1 or 2, rare genetic conditions that cause low blood calcium. Researchers will collect past and future health data from 95 participants to learn how the disease changes over time. The goal is to better understand…
Matched conditions: AUTOSOMAL DOMINANT HYPOCALCEMIA TYPE 1
Sponsor: Calcilytix Therapeutics, Inc., a BridgeBio company • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC